| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |